Skip to main content
. 2021 Nov 11;12:763323. doi: 10.3389/fimmu.2021.763323

Table 6.

Correlations between expressions of lncRNAs in study groups.

DSCAM-AS1 Controls 0.48* 0.0001
Patients 0.66* <0.0001
SPRY4-IT Controls 0.45* 0.0004 0.63* <0.0001
Patients 0.51* 0.0001 0.49* 0.0003
LINC-ROR Controls 0.31 0.0167 0.63* <0.0001 0.57* <0.0001
Patients 0.53* <0.0001 0.45 0.001 0.55* <0.0001
MEG3 Controls 0.33* 0.0096 0.60* <0.0001 0.42* 0.0008 0.61* <0.0001
Patients 0.46* 0.0006 0.35 0.0123 0.25 0.0738 0.49* 0.0003
PVT1 Controls 0.46* 0.0003 0.43* 0.0006 0.36 0.0051 0.47* 0.0002 0.44* 0.0006
Patients 0.34 0.0138 0.40 0.0035 0.32 0.0207 0.58* <0.0001 0.55* <0.0001
R P Value R P Value R P Value R P Value R P Value
HULC DSCAM-AS1 SPRY4-IT LINC-ROR MEG3

Correlations between expressions of lncRNAs in study groups (R values are presented; after correction for multiple comparisons (Bonferroni correction), P value less than 0.0016 was accepted as significant.

* shows significance.